AZELEX (Allergan, Inc.)
Welcome to the PulseAid listing for the AZELEX drug offered from Allergan, Inc.. This Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | azelaic acid |
| SUBSTANCE NAME: | AZELAIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE] |
| ROUTE: | CUTANEOUS |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-03-21 |
| END MARKETING DATE: | 0000-00-00 |
AZELEX HUMAN PRESCRIPTION DRUG Details:
| Item Description | AZELEX from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.2(g/g) |
| START MARKETING DATE: | 1996-03-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-8694_d7a96fba-04c1-4af1-9e4b-6e22d4e1fdd0 |
| PRODUCT NDC: | 0023-8694 |
| APPLICATION NUMBER: | NDA020428 |
Other AZELAIC ACID Pharmaceutical Manufacturers / Labelers:
